Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.12.12

Sai Life Sciences announces Sai Nxt, an initiative to transform the organization into a new generation CDMO

Sai Nxt

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO. Guided by the insights and feedback from its customers, the company is investing upwards of US $ 150 million over the period between 2019 and 2023 as a part of Sai Nxt, with a focus on three key areas :

  1. People & culture
  2. Processes & automation
  3. Infrastructure & scientific capabilities

Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, “Sai Nxt marks a transformative phase in our journey. Our growth over the years has essentially been driven by our scientific capabilities and customer focus. Raising the bar further, Sai Nxt will help us better serve the growing demand from global innovator pharma and biotech companies for speed and flexibility, with an assurance of compliance and dependability.”

Built on the foundation of partnership, Sai Life Sciences has grown to become one of India’s most trusted CDMOs. Coinciding with the completion of 20 years since its inception, Sai Nxt is the transformative lever aimed to propel the organization in the next phase of its growth.

Sai Nxt initiatives

  1. People & Culture: Expanding scientific talent pool, inducting top-notch global scientific and leadership talent, role-based integrated online training, shop floor transformation, nurturing culture of excellence
  2. Processes & Automation: Process simplification, strengthening governance systems, electronic manufacturing records, IT systems integration, foundation for seamless data capture across operations, leveraging latest technologies (RPA, IOT, AI / ML, AR/ VR) for innovation and intelligence
  3. Infrastructure & Capabilities: Biology lab in Cambridge (MA, USA), Process R&D lab in Manchester (UK), Integrated Discovery and Development campus, expanded suite of technology platforms, early phase delivery facility, flexible manufacturing with 2.5x capacity, advanced safety & quality systems

Through Sai Nxt, the company aims to significantly expand and upgrade its R&D and manufacturing facilities, deepen scientific & technological capabilities, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.

Share article

News

2021.04.01

Sustainable transformation stemming from the shop floor

Sustainable transformation
stemming from the shop floor

“You’ll never change your life unless you change something you do daily.” This well-known quote by John Maxwell rings true in the context of our shop floor management. We began with a small pilot of an interactive and inclusive program we call Shop Floor Transformation Initiative (SFTI) in one of our production blocks in December […]
Read more

2021.03.26

CII-SR EHS Excellence Awards

Sai Life Sciences manufacturing facility achieves 5-star rating at CII-SR EHS Excellence Awards

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRO/ CDMO), today announced that its flagship manufacturing facility in Bidar, Karnataka received a 5-star rating for excellence in EHS practices at the 13th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards. This is the second consecutive year […]
Read more

2021.03.24

Clean room block

Sai Life Sciences opens new clean room block at its manufacturing campus

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the opening of a new Clean Room block at its cGMP API & Intermediate Manufacturing campus in Bidar, India. Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, “Over the last two years […]
Read more

2021.03.11

International Women's Day

Soaring high this women's day

Adrenaline, enthusiasm and excitement were at peak levels at the JB Cricket Ground, Hyderabad, on International Women’s Day, March 8, 2021. Globally, the day celebrates achievements of women in social, economic, cultural and political spheres. This year’s theme ‘Choose to Challenge,’ marks a call to action to challenge gender biases and inequality. Women Saimers chose […]
Read more

2021.02.11

Dr. Mahavir Prashad joins Sai Life Sciences

Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the addition of Dr. Mahavir Prashad, an acknowledged scientific leader and industry veteran, to its scientific leadership team as Vice President of Early Phase Process Development. With over three decades of experience in advanced research and roles of […]
Read more